πŸ‡ΊπŸ‡Έ FDA
Patent

US 9657023

Polymorph of Syk inhibitors

granted A61PA61P11/06A61P19/02

Quick answer

US patent 9657023 (Polymorph of Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P11/06, A61P19/02, A61P25/00, A61P25/02